Jupiter Neurosciences faces Nasdaq delisting; appeals; bid price compliance regained

JUPITER NEUROSCIENCES, INC.

Received Nasdaq Staff notice on Aug 27, 2026 to delist common stock from Capital Market for failing to regain compliance with $35M market value requirement (Rule 5550(b)(2)) by Aug 25, 2026.
Company intends to appeal to Nasdaq Hearings Panel; hearing request expected to stay delisting pending final determination.
Regained compliance with $1.00 minimum bid price rule (5550(a)(2)) as of Aug 26, 2026; matter closed.
No assurance appeal will succeed or that compliance will be maintained.

Featured in Daily 8-K Digest

Selected #2 for 2026-08-28. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.